Keyphrases
Patient Assessment
100%
Neovascular Age-related Macular Degeneration (nAMD)
100%
National Assessment
100%
Quality of Life
14%
Developed Countries
14%
National Register
14%
Visual Impairment
14%
Advanced Age
14%
Telephone Interview
14%
Healthcare Professionals
14%
Preventive Measures
14%
Visual Function
14%
Vision Loss
14%
Previously Treated
14%
Patient Identification
14%
Patient Knowledge
14%
Access to Care
14%
Research Participation
14%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
14%
Visual Quality
14%
Retinal Image
14%
Reaching out
14%
Advisory Board
14%
Research Access
14%
Medicine and Dentistry
Wet Macular Degeneration
100%
Visual Impairment
28%
Quality of Life
14%
Vision
14%
Vasculotropin
14%
Retina Image
14%
Research Participation
14%
Nursing and Health Professions
Wet Macular Degeneration
100%
Visual Impairment
28%
Quality of Life
14%
Health Care Personnel
14%
Vasculotropin
14%